产品简要
公司名称 :
北京义翘神州
产品类型 :
抗体
产品名称 :
SARS-CoV / SARS-CoV-2 Nucleocapsid Antibody, Rabbit MAb
目录 :
40143-R001
规格 :
100微升
价格 :
290美元
克隆性 :
单克隆
宿主 :
domestic rabbit
共轭标签 :
未共轭
克隆名称 :
001
反应物种 :
SARS冠状病毒
应用 :
免疫印迹, 酶联免疫吸附测定
更多信息或购买 :
文章摘录数: 26
出版应用/物种/样本/稀释参考文献
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Renuse S, Vanderboom P, Maus A, Kemp J, Gurtner K, Madugundu A, et al. A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens. EBioMedicine. 2021;69:103465 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Sharma A, Ong J, Loke M, Chua E, Lee J, Choi H, et al. Comparative Transcriptomic and Molecular Pathway Analyses of HL-CZ Human Pro-Monocytic Cells Expressing SARS-CoV-2 Spike S1, S2, NP, NSP15 and NSP16 Genes. Microorganisms. 2021;9: pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Bennett R, Postnikova E, Liang J, Gross R, Mazur S, Dixit S, et al. Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples. Viruses. 2021;13: pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Xu X, Nie S, Wang Y, Long Q, Zhu H, Zhang X, et al. Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study. Signal Transduct Target Ther. 2021;6:197 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Zou W, Xiong M, Hao S, Zhang E, Baumlin N, Kim M, et al. The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia. MBio. 2021;12: pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Hodge C, Rosenberg D, Grob P, Wilamowski M, Joachimiak A, Hura G, et al. Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein. MAbs. 2021;13:1905978 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Putcharoen O, Wacharapluesadee S, Chia W, Paitoonpong L, Tan C, Suwanpimolkul G, et al. Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand. PLoS ONE. 2021;16:e0246864 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Bouwman K, Tomris I, Turner H, van der Woude R, Shamorkina T, Bosman G, et al. Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins. PLoS Pathog. 2021;17:e1009282 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Shanmugaraj B, Rattanapisit K, Manopwisedjaroen S, Thitithanyanont A, Phoolcharoen W. Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro. Front Plant Sci. 2020;11:589995 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Hao S, Ning K, Kuz C, Vorhies K, Yan Z, Qiu J. Long-Term Modeling of SARS-CoV-2 Infection of In Vitro Cultured Polarized Human Airway Epithelium. MBio. 2020;11: pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Graham N, Whitaker A, Strother C, Miles A, Grier D, McElvany B, et al. Kinetics and isotype assessment of antibodies targeting the spike protein receptor-binding domain of severe acute respiratory syndrome-coronavirus-2 in COVID-19 patients as a function of age, biological sex and disease severity. Clin Transl Immunology. 2020;9:e1189 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Torrente Rodríguez R, Lukas H, Tu J, Min J, Yang Y, Xu C, et al. SARS-CoV-2 RapidPlex: A Graphene-Based Multiplexed Telemedicine Platform for Rapid and Low-Cost COVID-19 Diagnosis and Monitoring. Matter. 2020;3:1981-1998 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Chiuppesi F, Salazar M, Contreras H, Nguyen V, Martinez J, Park S, et al. Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine. bioRxiv. 2020;: pubmed 出版商
Jeong B, Cha J, Hwang I, Kim U, Adolf Bryfogle J, Coventry B, et al. Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants. MAbs. 2022;14:2021601 pubmed 出版商
Bennett R, Postnikova E, Eaton B, Cai Y, Yu S, Smith C, et al. Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties. JCI Insight. 2022;7: pubmed 出版商
Maus A, Renuse S, Kemp J, Madugundu A, Vanderboom P, Blommel J, et al. Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides. J Proteome Res. 2022;21:142-150 pubmed 出版商
Jeong G, Yoon G, Moon H, Lee W, Hwang I, Kim H, et al. Comparison of Plaque Size, Thermal Stability, and Replication Rate among SARS-CoV-2 Variants of Concern. Viruses. 2021;14: pubmed 出版商
Kruse T, Benz C, Garvanska D, Lindqvist R, Mihalic F, Coscia F, et al. Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities. Nat Commun. 2021;12:6761 pubmed 出版商
Khan M, Yoo S, Clijsters M, Backaert W, Vanstapel A, Speleman K, et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell. 2021;184:5932-5949.e15 pubmed 出版商
Porzionato A, Emmi A, Contran M, Stocco E, Riccetti S, Sinigaglia A, et al. Case Report: The Carotid Body in COVID-19: Histopathological and Virological Analyses of an Autopsy Case Series. Front Immunol. 2021;12:736529 pubmed 出版商
Braga L, Ali H, Secco I, Chiavacci E, Neves G, Goldhill D, et al. Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia. Nature. 2021;594:88-93 pubmed 出版商
Szabolcs M, Sauter J, Frosina D, Geronimo J, Hernandez E, Selbs E, et al. Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues. Appl Immunohistochem Mol Morphol. 2021;29:5-12 pubmed 出版商
Chiuppesi F, Salazar M, Contreras H, Nguyen V, Martinez J, Park Y, et al. Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform. Nat Commun. 2020;11:6121 pubmed 出版商
Al Dalahmah O, Thakur K, Nordvig A, Prust M, Roth W, Lignelli A, et al. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol Commun. 2020;8:147 pubmed 出版商
Chiuppesi F, Salazar M, Contreras H, Nguyen V, Martinez J, Park S, et al. Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform. Res Sq. 2020;: pubmed 出版商
Salazar E, Kuchipudi S, Christensen P, Eagar T, Yi X, Zhao P, et al. Relationship between Anti-Spike Protein Antibody Titers and SARS-CoV-2 In Vitro Virus Neutralization in Convalescent Plasma. bioRxiv. 2020;: pubmed 出版商
图像
图像 1 :
北京义翘神州 40143-R001 图像 1
产品信息
提示 :
Online
目录代码 :
40143-R001
产品名称 :
SARS-CoV / SARS-CoV-2 Nucleocapsid Antibody, Rabbit MAb
产品类型 :
抗体
宿主物种 :
克隆性 :
单克隆
共轭 :
未共轭
抗体亚型 :
IgG
规格 :
100微升
标价 :
290美元
产品描述 :
This product is a recombinant monoclonal antibody expressed from HEK293 cells.
物种摘要 :
严重急性呼吸综合征
别名 :
NP-CoV
免疫原 :
Recombinant SARS-CoV Nucleoprotein / NP Protein (Catalog#40143-V08B)
特异性 :
SARS-CoV Nucleocapsid Protein
纯度 :
蛋白质A
缓冲液 :
0.2 μm filtered solution in PBS
应用摘要 :
免疫印迹, 酶联免疫吸附测定
储存 :
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
更多信息或购买 :
公司信息
北京义翘神州
北京市北京经济技术开发区科创十街18号院9号楼
Order@Sinobiological.com
http://www.sinobiological.cn
400-890-9989
公司总部: 中国
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务有重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。

义翘科技为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。义翘科技目前生产和销售的现货产品种类超过4.6万种,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求,并覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供“一站式”生物试剂产品和技术服务。

义翘科技的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,累计客户数量超过5,000个,品牌声誉不断累积,已成为生物试剂行业国内领先的科技公司之一。